ARCHIVES

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Gift To St. Jude: $1 Million McDonald’s Ticket; Leitch Elected President, ACS Texas Division

January 5, 1996

Bernard Fisher Settles Suit For $2.7M, Retains title, University Apologizes

September 5, 1997

Stop Suffering And Death “All Around Us”? Von Eschenbach Speeches At FDA Omit 2015 Goal.

February 17, 2006

Only Seven Of 66 “Benign” Breast Cancer Turn Out to Be Doubtful

November 25, 1977

NCCS Networker Volume 3 Issue 1, Winter 1989

January 13, 1989

Federal Hospitals Should Share Radiotherapy Facilitates: GAO

February 16, 1979